Affiliate-supportedIndependent editorialWe never sell medicationSee how
Channel: Real GLP-1 Stories • Published August 14, 2025
Note: This YouTube ID is a placeholder pending real-video curation. The page surface and schema are live; the embed will render once a real ID is published.
A patient documents twelve months on Wegovy, covering titration timing, side effects, and weight outcomes.
Paraphrased editorial summary by the GLP1Zoom team — not a verbatim transcript of the video.
The creator walks through their full year on Wegovy: starting at 0.25 mg with mild nausea, escalating to 0.5 mg with stronger early-onset GI side effects that resolved in roughly two weeks, then moving to 1 mg where appetite suppression became the dominant change. By 1.7 mg they describe an 8% body-weight loss at month 6 and a sharp decline in food noise. They note that hydration and a high-protein diet (>100 g/day) were essential for blunting nausea, and that constipation became the most persistent side effect after the first 90 days. By 2.4 mg maintenance, total loss reached approximately 18% body weight, in line with STEP-1 trial averages. They emphasize that the most underrated win was reduced cravings for alcohol and ultra-processed foods, which they attribute to GLP-1 effects on reward signaling. The reviewer cautions that injection site rotation matters, sharing that a bruised abdominal site led them to switch to thigh injection. Cost is acknowledged candidly: even with manufacturer savings, monthly out-of-pocket ran over $400 most months. They flag two stalls — months 4 and 9 — that both resolved without intervention, attributing them to natural set-point recalibration rather than tolerance. The video ends with what they would tell their past self: start protein and fiber tracking on day one, photograph progress weekly, and don't compare timelines with TikTok creators who often only show outlier results.
Honest, methodical 12-month review — one of the most representative Wegovy timelines we have found for a typical insured patient.
GLP1Zoom does not produce video content. We curate publicly available YouTube videos and write our own editorial summaries — paraphrased and factual, never verbatim. The video itself remains the property of its creator and is embedded via YouTube's privacy-enhanced no-cookie domain. This page is not sponsored. Read our editorial policy →